Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

By Larsen Mathilde S.   Bjerre Karsten   Giobbie-Hurder Anita   Lænkholm Anne-Vibeke   Henriksen Katrine L.   Ejlertsen Bent   Lykkesfeldt Anne E.   Rasmussen Birgitte B.  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 781-789

Informa Healthcare

Access to resources Recommend Favorite

Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

By Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite

Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer

By Sakurai Kenichi   Enomoto Katsuhisa   Amano Sadao  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 615-620

Springer Publishing Company

Access to resources Recommend Favorite

Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment

By Niikura Naoki  

Breast Cancer, Vol. 20, Iss. 1, 2013-01 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate?

By Cheung K.L.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite